Biomaterial Database

False-positive human T-lymphotropic virus serology after intravenous immunoglobulin transfusion. 2012

Sophie Savary Bélanger, and Douglas Fish, and John Kim, and Sandra Cohen

Faculté de médecine, Université de Montréal, Montréal, Québec, Canada. sophie.savary.belanger@umontreal.ca

UI	MeSH Term	Description	Entries
D007116	Immunization, Passive	Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).	Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008297	Male		Males
D005189	False Positive Reactions	Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed)	False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D006679	HIV Seropositivity	Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).	AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D000970	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS.	Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013118	Spinal Cord Diseases	Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.	Myelopathy,Spinal Cord Disorders,Myelopathies,Spinal Cord Disease,Spinal Cord Disorder
D015456	Leukemia, Biphenotypic, Acute	An acute leukemia exhibiting cell features characteristic of both the myeloid and lymphoid lineages and probably arising from MULTIPOTENT STEM CELLS.	B- and T-Cell Acute Lymphoblastic Leukemia,B- and T-Cell Leukemia, Acute,Leukemia, Lymphocytic, Acute, Mixed-Cell,Leukemia, Mixed, B- and T-Cell,Leukemia, Mixed-Cell,Lymphocytic Leukemia, Acute, B- and T-Cell,Acute Biphenotypic Leukemia,B and T Cell Acute Lymphoblastic Leukemia,B and T Cell Leukemia, Acute,Biphenotypic Acute Leukemia,Hybrid Acute Leukemias,Leukemia, Lymphocytic, Acute, Mixed Cell,Leukemia, Mixed, B and T Cell,Lymphocytic Leukemia, Acute, B and T Cell,Mixed-Lineage Acute Leukemias,Acute Biphenotypic Leukemias,Acute Leukemia, Biphenotypic,Acute Leukemia, Hybrid,Acute Leukemia, Mixed-Lineage,Acute Leukemias, Biphenotypic,Acute Leukemias, Hybrid,Acute Leukemias, Mixed-Lineage,Biphenotypic Acute Leukemias,Biphenotypic Leukemia, Acute,Biphenotypic Leukemias, Acute,Hybrid Acute Leukemia,Leukemia, Acute Biphenotypic,Leukemia, Biphenotypic Acute,Leukemia, Hybrid Acute,Leukemia, Mixed Cell,Leukemia, Mixed-Lineage Acute,Leukemias, Acute Biphenotypic,Leukemias, Biphenotypic Acute,Leukemias, Hybrid Acute,Leukemias, Mixed-Cell,Leukemias, Mixed-Lineage Acute,Mixed Lineage Acute Leukemias,Mixed-Cell Leukemia,Mixed-Cell Leukemias,Mixed-Lineage Acute Leukemia
D015480	Deltaretrovirus Antibodies	Antibodies reactive with various types of human T-cell leukemia/lymphoma antigens or bovine leukemia virus antigens.	BLV Antibodies,HTLV Antibodies,HTLV-BLV Antibodies,Human T-Cell Leukemia Virus Antibodies,Leukemia Virus Antibodies, Human T-Cell,Leukemia-Lymphoma Virus Antibodies, Human T-Cell,T-Cell Leukemia-Lymphoma Virus Antibodies, Human,Human T Cell Leukemia Virus Antibodies,Leukemia Lymphoma Virus Antibodies, Human T Cell,Leukemia Virus Antibodies, Human T Cell,T Cell Leukemia Lymphoma Virus Antibodies, Human,Antibodies, BLV,Antibodies, Deltaretrovirus,Antibodies, HTLV,Antibodies, HTLV-BLV,HTLV BLV Antibodies